Total mesorectal excision (TME) surgery

PROCEDURE2 trials

Sponsors

Shandong Cancer Hospital and Institute, Shanghai Zhongshan Hospital

Conditions

Rectal Cancer

Phase 2

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Not yet recruitingNCT06599827

Shanghai Zhongshan HospitalRectal Cancer

Start: 2024-09-20End: 2029-09-20Target: 54Updated: 2024-09-19

Unknown Phase

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

RecruitingNCT06246344

Shandong Cancer Hospital and InstituteRectal Cancer

Start: 2023-12-01End: 2028-12-01Target: 128Updated: 2025-03-12

Related Papers

Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial

Radiation Oncology2024-09-122 citations